查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1931219

胃造瘻管市場（按產品類型、應用、最終用戶和分銷管道分類），全球預測（2026-2032年）

Gastric or Gastrostomy Tubes Market by Product Type, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年胃造瘻管市場價值為 24.1 億美元，預計到 2026 年將成長至 25.1 億美元，年複合成長率為 5.45%，到 2032 年將達到 34.9 億美元。

關鍵市場統計數據
基準年 2025 24.1億美元
預計年份：2026年 25.1億美元
預測年份 2032 34.9億美元
複合年成長率 (%) 5.45%

簡要概述了正在重塑醫療保健領域胃管或胃造瘻管使用的臨床需求、設備發展和相關人員的優先事項。

胃造瘻管仍然是現代經腸營養治療的基礎組成部分，支持從短期減壓到長期營養治療等多種臨床目標。器械設計和置入技術的進步拓展了治療選擇，同時，住院和門診患者對安全性、舒適度和易用性的期望也日益提高。臨床醫生、供應鏈負責人和器械製造商正圍繞通用的目標開展合作：最大限度地降低併發症發生率，簡化置入和維護流程，並提供既能保證醫療品質又經濟高效的解決方案。

臨床、技術和營運因素驅動的重大變革正在重新定義腸內營養治療中的設備選擇、護理路徑和給藥方式。

隨著臨床、技術和操作趨勢的融合，胃造瘻管領域正經歷變革性的轉變。微創置入技術和更細器械的普及正在重新定義術後護理，促進患者更早從急性期護理過渡到門診和家庭護理。同時，材料創新和改進的固定機制正在減少器械相關併發症，這正在影響臨床醫生的選擇和醫療機構的籌資策略。

評估2025年對腸內營養輸注裝置生產徵收關稅的累積營運和策略影響（供應鏈、籌資策略和成本動態）。

2025年實施的新關稅措施對胃造瘻管產業的相關人員產生了重大的營運和策略影響。由於關稅上調和相關的物流成本上漲，依賴進口的零件，例如特殊聚合物、矽化合物和某些生產設備，其到岸成本均增加。依賴跨境供應鏈的製造商正在調整籌資策略，包括利用區域供應商和探索替代的原料規格，以降低關稅波動帶來的風險。

透過整合產品系列、臨床應用、使用者環境和通路，進行綜合細分分析，為採購和臨床通訊協定決策提供支援。

該領域的產品細分涵蓋了不同的器材系列，以滿足各種臨床場景和患者需求。器械可分為低輪廓設計、經皮視鏡系統和放射介入器。在低輪廓設計類別中，製造商區分球囊固定系統和緩衝墊固定系統，球囊固定系統又可進一步分為一次性使用和可重複填充兩種，以適應一次性使用通訊協定或長期治療。同樣，經皮視鏡產品也提供球囊固定或緩衝墊固定兩種選擇，以滿足臨床醫師的偏好和解剖結構方面的考慮；放射介入器材也採用類似的固定方式，以適應影像引導下的置入流程。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢和差異化應用模式影響供應、監管和臨床應用策略。

區域趨勢揭示了影響美洲、歐洲、中東和非洲以及亞太地區設備選擇、供應鏈策略和臨床實踐應用的不同促進因素和採用模式。在美洲，採用趨勢是由更新的臨床指南、報銷框架以及眾多重症監護機構優先選擇有助於縮短住院時間和減少術後併發症的設備等因素共同驅動的。因此，該地區的採購團隊優先考慮臨床證據、供應商可靠性以及與現有腸內治療工作流程的整合。

為確保腸內營養療法的長期應用，競爭定位和企業策略強調創新、實證夥伴關係和供應穩定性。

胃造瘻管市場的競爭格局以產品創新、生產規模以及透過證據證明其臨床性能的能力為特徵。領先的醫療器材製造商透過投資材料研發來提高生物相容性和耐用性，改善固定機制以減少併發症，並提升易用性以支持臨床醫生快速採納和居家安全使用，從而保持競爭優勢。

製造商和醫療保健領導者應重點關注以下切實可行的策略事項：整合創新、供應鏈韌性和臨床醫生支持，以實現持續應用並改善患者療效。

產業領導者應採取協作策略，將產品創新、供應鏈韌性和以臨床醫生為中心的服務相結合，以最大限度地提高產品普及率和患者療效。優先投資於能夠直接降低併發症率、簡化植入和維護的設備功能，從而解決臨床醫生和看護者面臨的關鍵挑戰。同時，應透過全面的培訓計畫和數位化賦能工具來完善產品開發，以加速臨床醫生的熟練度提升，並確保患者能夠安全地在家中進行長期治療。

採用嚴謹的混合方法調查方法，結合臨床訪談、監管分析、技術評估和通路分析，以產生可操作的洞見。

本調查方法結合了結構化的初步研究、嚴謹的二次研究和系統性的綜合分析，以確保研究結果能反映實際臨床實踐和當前的監管環境。初步研究包括對醫院、門診和居家醫療機構的臨床醫生進行訪談；與採購和供應鏈專業人員進行討論；以及與醫療器械工程師進行諮詢，以了解設計限制和製造方面的考慮因素。這些面對面的交流能夠提供關於醫療器材性能、培訓需求和推廣應用障礙的定性見解。

整合臨床、營運和策略方面的結論，以促進實證應用、供應穩定和以使用者為中心的醫療設備設計。

胃造瘻管或胃管仍是重要的臨床工具，其有效性取決於器械設計、臨床醫生技能和穩健的供應模式的綜合考慮。新型器械的創新和改進的手術流程有助於更安全地過渡到門診和居家照護，而日益嚴格的監管審查和關稅趨勢正在推動更具策略性的供應鏈配置。優先考慮臨床證據、多元化供應來源和終端用戶支援的相關人員將更有能力應對營運壓力並改善患者預後。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依產品類型分類的胃管或胃造瘻管市場

  • 經皮視鏡
  • 放射插入

9. 依應用分類的胃管或胃造瘻管市場

  • 引流
    • 胃減壓
    • 胃內容物採集
  • 藥物管理
    • 液體藥物
    • 粉狀藥物
  • 營養補充
    • Bolus餵
    • 持續的營養支持

10. 依最終使用者分類的胃造瘻管或胃管市場

  • 門診手術中心
  • 居家醫療
    • 護理服務
    • 自我管理
  • 醫院

11. 依分銷管道分類的胃造瘻管市場

  • 離線
  • 線上

12. 各地區胃造瘻管市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

13. 依組別分類的胃造瘻管或胃管市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各國胃造瘻管市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

15. 美國胃造瘻管市場

16. 中國：胃造瘻管市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Amsino International, Inc.
  • Applied Medical Technology, Inc.
  • Avanos Medical, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Coloplast A/S
  • CONMED Corporation
  • ConvaTec Group PLC
  • Cook Medical Incorporated
  • Danone SA
  • Fresenius Kabi AG
  • Halyard Health, Inc.
  • Hollister Incorporated
  • Kimberly-Clark Corporation
  • Mead Johnson Nutrition Company
  • Medtronic plc
  • Moog Inc.
  • Nestle Health Science
  • Smiths Medical
  • Vygon SA
Product Code: MRR-7B550E008DC7

The Gastric or Gastrostomy Tubes Market was valued at USD 2.41 billion in 2025 and is projected to grow to USD 2.51 billion in 2026, with a CAGR of 5.45%, reaching USD 3.49 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.41 billion
Estimated Year [2026] USD 2.51 billion
Forecast Year [2032] USD 3.49 billion
CAGR (%) 5.45%

A concise orientation explaining clinical imperatives, device evolution, and stakeholder priorities reshaping gastric and gastrostomy tube utilization across care settings

Gastric and gastrostomy tubing remains a foundational component of modern enteral care, supporting diverse clinical objectives from short-term decompression to long-term nutritional therapy. Advances in device design and insertion techniques have expanded therapeutic options while elevating expectations for safety, patient comfort, and usability across inpatient and outpatient settings. Clinicians, supply chain leaders, and device manufacturers are convening around common priorities: minimizing complication rates, streamlining insertion and maintenance workflows, and delivering cost-efficient solutions that preserve quality of care.

Over the past decade, incremental innovation in materials science, retention mechanisms, and low-profile form factors has altered procurement criteria and clinical protocols. Simultaneously, regulatory scrutiny and reimbursement considerations have prompted more rigorous evidence generation and post-market surveillance. This combination of clinical demand and regulatory pressure has accelerated adoption of devices that demonstrably reduce adverse events and decrease caregiver burden. Consequently, decision-makers are evaluating devices not only on product specifications but also on training requirements, compatibility with existing inventory, and the ability of suppliers to guarantee consistent quality and timely delivery.

Key transformative shifts driven by clinical, technological, and operational forces that are redefining device selection, care pathways, and supply approaches in enteral access therapy

The landscape for gastric and gastrostomy tubes is undergoing transformative shifts driven by converging clinical, technological, and operational trends. Minimally invasive insertion techniques and expanded use of low-profile devices are redefining post-procedure management, encouraging earlier transitions from acute care to outpatient and home-based therapy. Concurrently, material innovations and improved retention mechanisms are reducing device-related complications, which in turn influences clinician preferences and institutional procurement strategies.

Operational pressures within hospitals and ambulatory centers are prompting greater emphasis on product standardization and supplier consolidation to achieve predictable inventory turnover and simplified clinician training. At the same time, the rise of telehealth-enabled home healthcare monitoring and more robust caregiver education programs is supporting safe long-term gastrostomy care outside hospital walls. Moreover, heightened regulatory attention to device labeling and adverse event reporting is encouraging manufacturers to invest in clinical evidence and quality systems, thus raising the bar for market entry and reinforcing the competitive advantage of established players with proven compliance capabilities.

Assessing the cumulative operational and strategic effects of 2025 tariff measures on supply chains, sourcing strategies, and cost dynamics within enteral access device production

The implementation of new tariff measures in 2025 has created material operational and strategic implications for stakeholders in the gastric and gastrostomy tubes space. Import-sensitive components such as specialized polymers, silicone compounds, and certain manufacturing equipment have experienced elevated landed costs due to increased duties and associated logistical premiums. Manufacturers that rely on cross-border supply chains have adjusted sourcing strategies, seeking regional suppliers or alternative input specifications to mitigate exposure to tariff volatility.

In response, device producers have pursued several adaptation pathways. Some have localized critical manufacturing steps or established regional assembly hubs to preserve competitiveness and shorten inbound lead times. Others have restructured supplier contracts to shift cost-sharing dynamics or accelerated qualification of alternative materials that meet clinical and regulatory benchmarks. For purchasers, procurement cycles now incorporate tariff impact assessments when evaluating total cost of ownership and long-term vendor relationships. Healthcare providers and group purchasing organizations are increasingly requesting transparency on tariff-related cost components and supplier resilience plans to ensure continuity of care and to avoid unforeseen budgetary pressures.

Furthermore, tariff-driven cost adjustments have incentivized efficiency gains across manufacturing and distribution, prompting investments in automation, process optimization, and inventory management technologies. These operational responses aim to offset tariff-induced input cost increases while preserving product quality and maintaining access across care settings. As a result, stakeholders who proactively addressed tariff exposure through supply diversification and process improvements are better positioned to sustain service levels and manage procurement predictably.

Integrated segmentation analysis linking product families, clinical applications, user environments, and distribution pathways to inform procurement and clinical protocol decisions

Product segmentation in this sector encompasses distinct device families that align with varied clinical scenarios and patient needs. Devices are grouped under low-profile designs, percutaneous endoscopic systems, and radiologically inserted devices. Within the low-profile category, manufacturers differentiate between balloon retention and bumper retention modalities, with balloon variants further divided into one-time and refillable options to support single-use protocols or longer-term therapy. Similarly, percutaneous endoscopic products are available with either balloon or bumper retention to accommodate clinician preference and anatomical considerations, and radiologically inserted devices mirror these retention configurations to suit image-guided placement workflows.

Applications for these devices span drainage, medication administration, and nutrition delivery, reflecting the procedural and therapeutic breadth of enteral access. Drainage use cases include gastric decompression and gastric sampling, each carrying specific design and handling requirements. Medication administration spans liquid and powdered formulations, driving requirements for lumen size, port design, and flushing protocols. Nutrition delivery differentiates between bolus feeding and continuous feeding regimens, which influence tube diameter, material resilience, and compatibility with feeding pumps.

End users range from ambulatory surgical centers and home healthcare settings to hospital environments, each imposing unique operational constraints and service expectations. Ambulatory surgical centers include day surgery centers and outpatient clinics where rapid turnover and simple device handling are prioritized. Home healthcare encompasses nursing service support and self-administration contexts, emphasizing ease of use, caregiver training, and remote support. Hospitals cover both secondary and tertiary care facilities with diverse procedural volumes and complexity profiles.

Distribution channels shape product accessibility and procurement cadence through direct tenders, distributor networks, and online platforms. Distributors include local wholesalers and specialized medical distributors that provide logistical reach and inventory services, while online channels encompass e-commerce vendors and original equipment manufacturer platforms that offer direct access and digital ordering convenience. The interplay of product features, clinical applications, user environment, and distribution pathways informs purchasing decisions, clinical guidelines, and supplier selection processes, requiring an integrated assessment when evaluating new device introductions or standardizing formularies.

Regional dynamics and differentiated adoption patterns across the Americas, Europe Middle East & Africa, and Asia-Pacific that inform supply, regulation, and clinical adoption strategies

Regional trends demonstrate distinct drivers and adoption patterns across the Americas, Europe, Middle East & Africa, and Asia-Pacific regions that influence device selection, supply chain strategies, and clinical practice adoption. In the Americas, adoption is often guided by a combination of clinical guideline updates, reimbursement frameworks, and a concentration of advanced acute care centers that favor devices reducing length of stay and post-procedure complications. Consequently, procurement teams in this region emphasize clinical evidence, supplier reliability, and integration with existing enteral therapy workflows.

In Europe, Middle East & Africa, regulatory harmonization efforts and cross-border procurement practices influence manufacturer strategies, with larger health systems and national procurement bodies seeking long-term supplier partnerships and consistent quality standards. Variability in healthcare infrastructure across this combined region creates demand for both high-end specialty devices suited for tertiary centers and cost-effective solutions tailored to resource-constrained settings. This dynamic stimulates product tiering and adaptable device portfolios.

Asia-Pacific exhibits rapid adoption of minimally invasive techniques and growing investment in outpatient and home-based care infrastructure. Manufacturer investments in regional production and distribution hubs are common to address logistical complexities and to shorten lead times. Across all regions, local clinical training programs, regulatory requirements, and supply chain resilience considerations shape uptake patterns, highlighting the need for manufacturers to align product design and commercial strategies with regional clinical workflows and procurement expectations.

Competitive positioning and corporate strategies emphasizing innovation, evidence partnerships, and supply resilience to secure long-term adoption in enteral access therapy

Competitive dynamics in the gastric and gastrostomy tubes landscape are characterized by product innovation, manufacturing scale, and the ability to demonstrate clinical performance through evidence generation. Leading device manufacturers maintain competitive advantage by investing in materials research to improve biocompatibility and durability, refining retention mechanisms to reduce complications, and enhancing usability features that support rapid clinician adoption and safe home use.

Partnerships between device companies and clinical centers have become an important pathway for iterative product improvement and real-world evidence collection. These collaborations support post-market surveillance and comparative performance assessments, informing labeling updates and clinician training programs. Additionally, strategic alliances with distribution partners and healthcare systems enable efficient inventory management and broaden access in outpatient and home settings.

Supply chain resilience and regulatory compliance are increasingly central to competitive positioning. Firms that have diversified component sourcing, developed regional manufacturing footprints, and implemented robust quality management systems are better equipped to manage disruptions and meet diverse regulatory requirements. Finally, companies that offer integrated service packages-including clinician training, remote monitoring tools, and comprehensive warranty and support programs-tend to achieve stronger uptake among hospitals, ambulatory centers, and home healthcare providers who value total cost of care and patient safety outcomes.

Actionable strategic priorities for manufacturers and healthcare leaders to align innovation, supply resilience, and clinician support for sustainable adoption and improved outcomes

Industry leaders should pursue a coordinated strategy that aligns product innovation with supply chain resilience and clinician-focused services to maximize adoption and patient outcomes. Prioritize investments in device features that directly reduce complication rates and simplify insertion and maintenance, thereby addressing the primary clinician and caregiver pain points. Complement product development with comprehensive training programs and digital support tools that accelerate clinician proficiency and enable safe home-based management of long-term therapies.

Strengthen supplier networks by qualifying alternative material sources and establishing regional assembly or finishing capabilities to reduce tariff exposure and shorten delivery timelines. Contractual frameworks that emphasize transparency on cost drivers and contingency planning will support stronger procurement relationships with healthcare systems. Additionally, cultivating partnerships with leading clinical centers to generate real-world evidence and post-market safety data enhances credibility and supports adoption across a broader range of care settings. Finally, design commercial models that accommodate diverse procurement channels-from direct tenders to e-commerce platforms-while offering configurable service tiers to meet the needs of tertiary hospitals, ambulatory centers, and home healthcare providers.

A rigorous mixed-methods research approach combining clinical interviews, regulatory analysis, technical review, and distribution channel mapping to produce actionable intelligence

The research methodology combines structured primary engagements, rigorous secondary review, and systematic synthesis to ensure findings reflect practical clinical realities and current regulatory landscapes. Primary inputs include interviews with clinicians across hospital, ambulatory, and home healthcare environments, discussions with procurement and supply chain professionals, and consultations with device engineers to understand design constraints and manufacturing considerations. These direct interactions provide qualitative insights into device performance, training needs, and adoption barriers.

Secondary analysis encompassed a comprehensive review of regulatory guidance documents, clinical practice guidelines, and device labeling to contextualize safety expectations and compliance trends. Patent literature and technical specifications were examined to identify material and design innovations. Distribution channel dynamics were analyzed through supplier network mapping and platform capability assessments to understand how access and procurement pathways vary by region. Throughout the process, data integrity was assured via triangulation across sources and validation checkpoints with industry experts, enabling a robust synthesis that supports actionable recommendations for stakeholders.

Synthesis of clinical, operational, and strategic conclusions emphasizing evidence-driven adoption, supply stability, and user-centered device design

Gastric and gastrostomy tubes remain essential clinical tools whose effectiveness depends on the confluence of device design, clinician competency, and resilient supply models. Emerging device innovations and procedural refinements are enabling safer transitions to outpatient and home-based care, while regulatory scrutiny and tariff dynamics are prompting more strategic supply chain configurations. Stakeholders that prioritize clinical evidence, supply diversification, and end-user support will be better positioned to navigate operational pressures and to improve patient outcomes.

Decision-makers should view device selection through a systems lens that accounts for insertion workflows, post-procedural care, caregiver capabilities, and distribution reliability. By aligning product portfolios with clinical needs and by investing in training and service infrastructure, manufacturers and providers can reduce complications, streamline care pathways, and expand access to appropriate enteral therapies. In summary, the sector's near-term trajectory favors practical innovations that deliver measurable improvements in safety, usability, and operational predictability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gastric or Gastrostomy Tubes Market, by Product Type

  • 8.1. Percutaneous Endoscopic
  • 8.2. Radiologically Inserted

9. Gastric or Gastrostomy Tubes Market, by Application

  • 9.1. Drainage
    • 9.1.1. Gastric Decompression
    • 9.1.2. Gastric Sampling
  • 9.2. Medication Administration
    • 9.2.1. Liquid Medication
    • 9.2.2. Powdered Medication
  • 9.3. Nutrition
    • 9.3.1. Bolus Feeding
    • 9.3.2. Continuous Feeding

10. Gastric or Gastrostomy Tubes Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Home Healthcare
    • 10.2.1. Nursing Service
    • 10.2.2. Self Administration
  • 10.3. Hospitals

11. Gastric or Gastrostomy Tubes Market, by Distribution Channel

  • 11.1. Offline
  • 11.2. Online

12. Gastric or Gastrostomy Tubes Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Gastric or Gastrostomy Tubes Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Gastric or Gastrostomy Tubes Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Gastric or Gastrostomy Tubes Market

16. China Gastric or Gastrostomy Tubes Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Amsino International, Inc.
  • 17.7. Applied Medical Technology, Inc.
  • 17.8. Avanos Medical, Inc.
  • 17.9. B. Braun Melsungen AG
  • 17.10. Baxter International Inc.
  • 17.11. Becton, Dickinson and Company
  • 17.12. Boston Scientific Corporation
  • 17.13. Cardinal Health, Inc.
  • 17.14. Coloplast A/S
  • 17.15. CONMED Corporation
  • 17.16. ConvaTec Group PLC
  • 17.17. Cook Medical Incorporated
  • 17.18. Danone S.A.
  • 17.19. Fresenius Kabi AG
  • 17.20. Halyard Health, Inc.
  • 17.21. Hollister Incorporated
  • 17.22. Kimberly-Clark Corporation
  • 17.23. Mead Johnson Nutrition Company
  • 17.24. Medtronic plc
  • 17.25. Moog Inc.
  • 17.26. Nestle Health Science
  • 17.27. Smiths Medical
  • 17.28. Vygon S.A.

LIST OF FIGURES

  • FIGURE 1. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PERCUTANEOUS ENDOSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PERCUTANEOUS ENDOSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PERCUTANEOUS ENDOSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY RADIOLOGICALLY INSERTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY RADIOLOGICALLY INSERTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY RADIOLOGICALLY INSERTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY GASTRIC DECOMPRESSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY GASTRIC DECOMPRESSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY GASTRIC DECOMPRESSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY GASTRIC SAMPLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY GASTRIC SAMPLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY GASTRIC SAMPLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY LIQUID MEDICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY LIQUID MEDICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY LIQUID MEDICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY POWDERED MEDICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY POWDERED MEDICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY POWDERED MEDICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY BOLUS FEEDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY BOLUS FEEDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY BOLUS FEEDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY CONTINUOUS FEEDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY CONTINUOUS FEEDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY CONTINUOUS FEEDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NURSING SERVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NURSING SERVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NURSING SERVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY SELF ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY SELF ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. GCC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GCC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. GCC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. GCC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 151. GCC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 152. GCC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 153. GCC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. GCC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 155. GCC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. G7 GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. G7 GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. G7 GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. G7 GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 178. G7 GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 179. G7 GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 180. G7 GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. G7 GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 182. G7 GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. NATO GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. NATO GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. NATO GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. NATO GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 187. NATO GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 188. NATO GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 189. NATO GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. NATO GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 191. NATO GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)